Advisors Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.9M | Buy |
117,191
+3,332
| +3% | +$922K | 0.27% | 116 |
|
|
2026
Q1 | $33.6M | Buy |
113,859
+958
| +0.8% | +$285K | 0.39% | 84 |
|
|
2025
Q4 | $30.8M | Buy |
112,901
+2,914
| +3% | +$792K | 0.36% | 86 |
|
|
2025
Q3 | $29.7M | Buy |
109,987
+1,647
| +2% | +$448K | 0.37% | 83 |
|
|
2025
Q2 | $29.9M | Buy |
108,340
+4,550
| +4% | +$1.24M | 0.41% | 77 |
|
|
2025
Q1 | $27.5M | Buy |
103,790
+972
| +0.9% | +$240K | 0.43% | 73 |
|
|
2024
Q4 | $23.9M | Buy |
102,818
+864
| +0.8% | +$199K | 0.38% | 82 |
|
|
2024
Q3 | $22.5M | Buy |
101,954
+156
| +0.2% | +$32.3K | 0.37% | 88 |
|
|
2024
Q2 | $20M | Buy |
101,798
+2,596
| +3% | +$536K | 0.35% | 89 |
|
|
2024
Q1 | $21.4M | Buy |
99,202
+16,690
| +20% | +$3.51M | 0.39% | 82 |
|
|
2023
Q4 | $17.4M | Buy |
82,512
+2,118
| +3% | +$452K | 0.35% | 92 |
|
|
2023
Q3 | $16.1M | Sell |
80,394
-620
| -0.8% | -$123K | 0.41% | 84 |
|
|
2023
Q2 | $15M | Buy |
81,014
+2,999
| +4% | +$554K | 0.36% | 96 |
|
|
2023
Q1 | $14.9M | Buy |
78,015
+1,654
| +2% | +$299K | 0.39% | 90 |
|
|
2022
Q4 | $12.8M | Sell |
76,361
-7,785
| -9% | -$1.35M | 0.35% | 93 |
|
|
2022
Q3 | $14.6M | Buy |
84,146
+26,175
| +45% | +$5.17M | 0.39% | 80 |
|
|
2022
Q2 | $11.9M | Buy |
57,971
+3,258
| +6% | +$691K | 0.36% | 87 |
|
|
2022
Q1 | $13M | Buy |
54,713
+1,525
| +3% | +$358K | 0.36% | 88 |
|
|
2021
Q4 | $12.2M | Buy |
53,188
+3,144
| +6% | +$692K | 0.33% | 94 |
|
|
2021
Q3 | $9.68M | Buy |
50,044
+2,666
| +6% | +$540K | 0.3% | 105 |
|
|
2021
Q2 | $10.1M | Buy |
47,378
+2,842
| +6% | +$600K | 0.32% | 101 |
|
|
2021
Q1 | $9.1M | Buy |
44,536
+3,306
| +8% | +$651K | 0.32% | 99 |
|
|
2020
Q4 | $7.5M | Buy |
41,230
+2,789
| +7% | +$474K | 0.29% | 104 |
|
|
2020
Q3 | $6.43M | Buy |
38,441
+4,509
| +13% | +$760K | 0.3% | 103 |
|
|
2020
Q2 | $5.51M | Buy |
33,932
+20,545
| +153% | +$3.68M | 0.27% | 102 |
|
|
2020
Q1 | $2.31M | Buy |
13,387
+4,988
| +59% | +$993K | 0.15% | 131 |
|
|
2019
Q4 | $1.69M | Buy |
8,399
+13
| +0.2% | +$2.67K | 0.08% | 190 |
|
|
2019
Q3 | $1.77M | Buy |
8,386
+561
| +7% | +$117K | 0.1% | 170 |
|
|
2019
Q2 | $1.52M | Buy |
7,825
+536
| +7% | +$98.8K | 0.09% | 170 |
|
|
2019
Q1 | $1.21M | Buy |
7,289
+375
| +5% | +$66.3K | 0.08% | 178 |
|
|
2018
Q4 | $1.3M | Buy |
+6,914
| New | +$1.28M | 0.09% | 171 |
|
Other funds holding CME
Advisors Capital Management's CME Position: Q2 2026 in Review
Advisors Capital Management increased its CME Group (CME) stake by 2.9% in Q2 2026, buying an estimated $922K and bringing the position to 117,191 shares worth $25.9M. The position accounts for 0.27% of the portfolio, ranked #116.
Advisors Capital Management first reported a position in CME in Q4 2018 and has held it in 31 quarters since. The position peaked at $33.6M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Advisors Capital Management held 117,191 shares of CME Group worth $25.9M as of Q2 2026.
- Advisors Capital Management bought 3,332 CME Group shares in Q2 2026, an estimated $922K.
- CME Group made up 0.27% of Advisors Capital Management's portfolio in Q2 2026, its #116 holding.
- Advisors Capital Management first reported a position in CME Group in Q4 2018 and has held it in 31 quarters since.
- Advisors Capital Management's CME Group position peaked at $33.6M in Q1 2026.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.